The Neuro Engraftment and Neuroregenerative effects of Hydrogen Sulphide Donor, Intracerebral MSCs, Ginko Biloba and Kefir in Attenuating Neuropathological hallmarks of Lipopolysaccharide induced Alzheimer’s disease Rat models


The Neuro Engraftment and Neuroregenerative effects of Hydrogen Sulphide Donor, Intracerebral MSCs, Ginko Biloba and Kefir in Attenuating Neuropathological hallmarks of Lipopolysaccharide induced Alzheimer’s disease Rat models


Mai M.Anwar1, Ola S.M.Ali2, Laila A. Rashed.3, Badawi A.M.1, Nadia A.Eltablawy1

1Department of Biochemistry, National Organization for Drug Control and Research (NODCAR), Giza 12511, Egypt. 2Department of Biochemistry, Faculty of Pharmacy, Al-Azhar University, cairo 11311, Egypt. 3Department of Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Giza 12511, Egypt.


international journal of aging research

Background: Memory disorders have been characterized by being a devastating long term incurable diseases with a huge social impact in addition to a diminished efficient available medical treatments. Deep Brain stimulation via using neuroprotective inducers for treatment of brain structure degenerative diseases such as Alzheimer’s disease (AD) can be considered as being a promising successful therapy due to its various targets and underlying mechanisms for improving brain dysfunction. Objectives: The main aim of this study is to suggest therapeutic protocol having the potentials for restoring normal neurons diverse population and modifying neuropathological deposited hallmarks including both positive and negative lesions. Materials and Methods: Rats were divided into nine groups: (G1) control ;(G2) rats received LPS as a method of inducing nongenetically manipulated AD;(G3)AD rats received NaHS;(G4) AD rats received MSCs intracerebrally;(G5) AD rats received MSCs+NaHS;(G6)AD rats received kefir+GB;(G7)AD rats received MSCs+kefir+GB;(G8)AD rats received NaHS+kefir+GB; (G9) AD rats received MSCs+NaHS+kefir+GB. Results: AD induction resulted in down-regulation of CBS expression and GSH brain tissue level accompanied with overexpression in amyloid-β protein, MAPK, tau protein, ACAT expression and MDA brain tissue level in addition to elevated caspase-3 serum level. Conclusion: The implantation of amyloid reliving therapy that do have a wide clinical impact if initiated at benign plaques stage before irreversible brain damage occurs. The following effects have been observed following the administration of suggested medical protocol where a decrease in AD pathological deposited hallmarks has been observed with maintaining inflammatory brain factors by functioning as a potent neuroregenerative.


Keywords: LPS induced rats, MSCs, hydrogen sulphide, Kefir, amyloid β, intracerebral.


Free Full-text PDF


How to cite this article:
Mai M.Anwar, Ola S.M.Ali, Laila A. Rashed., Badawi A.M., Nadia A.Eltablawy. The Neuro Engraftment and Neuroregenerative effects of Hydrogen Sulphide Donor, Intracerebral MSCs, Ginko Biloba and Kefir in Attenuating Neuropathological hallmarks of Lipopolysaccharide induced Alzheimer’s disease Rat models . International Journal of Aging Research, 2019, 2:38. DOI: 10.28933/ijoar-2019-06-2005


References:

[1] Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007;29:125-32.
[2] Lee H, Fell J, Axmacher N. Electrical engram: how deep brain stimulation affects memory. Trends in cognitive sciences 2013;17:574-84.
[3] Hardenacke K, Kuhn J, Lenartz D, Maarouf M, Mai JK, Bartsch C, et al. Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia. World neurosurgery 2013;80:S27.e35-43.
[4] Lyketsos CG, Targum SD, Pendergrass JC, Lozano AM. Deep brain stimulation: a novel strategy for treating Alzheimer’s disease. Innovations in clinical neuroscience 2012;9:10-7.
[5] Hescham S, Lim LW, Jahanshahi A, Steinbusch HW, Prickaerts J, Blokland A, et al. Deep brain stimulation of the forniceal area enhances memory functions in experimental dementia: the role of stimulation parameters. Brain stimulation 2013;6:72-7.
[6] Sperling RA, Laviolette PS, O’Keefe K, O’Brien J, Rentz DM, Pihlajamaki M, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009;63:178-88.
[7] Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A 2001;98:676-82.
[8] Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007;55:453-62.
[9] DiCarlo G, Wilcock D, Henderson D, Gordon M, Morgan D. Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiology of aging 2001;22:1007-12.
[10] Savage JC, Gould DH. Determination of sulfide in brain tissue and rumen fluid by ion-interaction reversed-phase high-performance liquid chromatography. Journal of chromatography 1990;526:540-5.
[11] Rosova I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem cells (Dayton, Ohio) 2008;26:2173-82.
[12] Zhang X, Bian JS. Hydrogen sulfide: a neuromodulator and neuroprotectant in the central nervous system. ACS chemical neuroscience 2014;5:876-83.
[13] Ali OS, Rashed LA, Badawi AM, Anwar MM. The Approaching Therapy Targeting Alzheimer’s disease using Kefir grain and Mesenchymal Stem Cells International journal of Applied Pharmaceutical and biological Research 2016;11-21:2456-0189
[14] Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circulation research 2004;94:678-85.
[15] Wu P-f, Zhang Z, Wang F, Chen J-g. Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury. Acta pharmacologica Sinica 2010;31:1523-31.
[16] Greenberg DA. Neurogenesis and stroke. CNS & neurological disorders drug targets 2007;6:321-5.
[17] Yu TS, Zhang G, Liebl DJ, Kernie SG. Traumatic brain injury-induced hippocampal neurogenesis requires activation of early nestin-expressing progenitors. The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28:12901-12.
[18] Tchantchou F, Xu Y, Wu Y, Christen Y, Luo Y. EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer’s disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21:2400-8.
[19] Nada SE, Tulsulkar J, Shah ZA. Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (EGb 761(R)) after permanent ischemic stroke in mice. Molecular neurobiology 2014;49:945-56.
[20] Heurteaux C, Gandin C, Borsotto M, Widmann C, Brau F, Lhuillier M, et al. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo. Neuropharmacology 2010;58:987-1001.
[21] Diamond BJ, Bailey MR. Ginkgo biloba: indications, mechanisms, and safety. The Psychiatric clinics of North America 2013;36:73-83.
[22] Garrote GL, Abraham AG, De Antoni GL. Chemical and microbiological characterisation of kefir grains. The Journal of dairy research 2001;68:639-52.
[23] Shah NP. Functional cultures and health benefits. International Dairy Journal 2007;17:1262-77.
[24] Farnworth ER. Kefir – a complex probiotic. Food Sci TechnolBull 2005;2:1–17.
[25] Lopitz-Otsoa F, Rementeria A, Elguezabal N, Garaizar J. Kefir: a symbiotic yeasts-bacteria community with alleged healthy capabilities. Revista iberoamericana de micologia 2006;23:67-74.
[26] Liu JR, Wang SY, Lin YY, Lin CW. Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice. Nutrition and cancer 2002;44:183-7.
[27] Blecharz-Klin K, Piechal A, Joniec I, Pyrzanowska J, Widy-Tyszkiewicz E. Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats. Acta neurobiologiae experimentalis 2009;69:217-31.
[28] Xuan A, Long D, Li J, Ji W, Zhang M, Hong L, et al. Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer’s disease. Journal of neuroinflammation 2012;9:202.
[29] Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. Journal of cellular biochemistry 1997;64:295-312.
[30] El Sayed NS, Kassem LA, Heikal OA. Promising therapy for Alzheimer’s disease targeting angiotensinconverting enzyme and the cyclooxygense-2 isoform. Drug discoveries & therapeutics 2009;3:307-15.
[31] Israel Y, Ezquer F, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M. Intracerebral Stem Cell Administration Inhibits Relapse-like Alcohol Drinking in Rats. Alcohol and alcoholism 2017;52:1-4.
[32] Liu C, Voth DW, Rodina P, Shauf LR, Gonzalez G. A comparative study of the pathogenesis of western equine and eastern equine encephalomyelitis viral infections in mice by intracerebral and subcutaneous inoculations. The Journal of infectious diseases 1970;122:53-63.
[33] Pugach EK, Finley KR, Zon LI. Chapter 52 – Zebrafish and Stem Cell Research A2 – Lanza, Robert. In: Gearhart J, Hogan B, Melton D, Pedersen R, Thomas ED, Thomson J, et al., editors. Essentials of Stem Cell Biology (Second Edition). San Diego: Academic Press; 2009, p. 459-66.
[34] Shimizu S. CHAPTER 32 – Routes of Administration A2 – Hedrich, Hans J. In: Bullock G, editor The Laboratory Mouse. London: Academic Press; 2004, p. 527-42.
[35] Benedikz E, Kloskowska E, Winblad B. The rat as an animal model of Alzheimer’s disease. Journal of cellular and molecular medicine 2009;13:1034-42.
[36] Wang X, Liu D, Huang HZ, Wang ZH, Hou TY, Yang X, et al. A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer’s Disease. Biological psychiatry 2018;83:395-405.
[37] Fang M, Wang J, Zhang X, Geng Y, Hu Z, Rudd JA, et al. The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimer’s disease. Toxicology letters 2012;209:94-105.
[38] Lukiw WJ. Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer’s disease (AD). Expert opinion on emerging drugs 2008;13:255-71.
[39] Lukiw WJ. NF-κB-regulated micro RNAs (miRNAs) in primary human brain cells. Experimental neurology 2012;235:484-90.
[40] Paeschke N, von Haefen C, Endesfelder S, Sifringer M, Spies CD. Dexmedetomidine Prevents Lipopolysaccharide-Induced MicroRNA Expression in the Adult Rat Brain. International journal of molecular sciences 2017;18.
[41] Sun Y, Qin Z, Li Q, Wan JJ, Cheng MH, Wang PY, et al. MicroRNA-124 negatively regulates LPS-induced TNF-alpha production in mouse macrophages by decreasing protein stability. Acta pharmacologica Sinica 2016;37:889-97.
[42] Sun Y, Li Q, Gui H, Xu DP, Yang YL, Su DF, et al. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell research 2013;23:1270-83.
[43] Nikolakopoulou AM, Dutta R, Chen Z, Miller RH, Trapp BD. Activated microglia enhance neurogenesis via trypsinogen secretion. Proc Natl Acad Sci U S A 2013;110:8714-9.
[44] Roughton K, Andreasson U, Blomgren K, Kalm M. Lipopolysaccharide-Induced Inflammation Aggravates Irradiation-Induced Injury to the Young Mouse Brain. Developmental Neuroscience 2013;35:406-15.
[45] Veremeyko T, Siddiqui S, Sotnikov I, Yung A, Ponomarev ED. IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PloS one 2013;8:e81774.
[46] Dalrymple SA. p38 mitogen activated protein kinase as a therapeutic target for Alzheimer’s disease. Journal of molecular neuroscience : MN 2002;19:295-9.
[47] Marr RA, Hafez DM. Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance. Front Aging Neurosci 2014;6:187.
[48] Lee JK, Kim NJ. Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer’s Disease. Molecules (Basel, Switzerland) 2017;22.
[49] Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox biology 2018;14:450-64.
[50] Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J. Amyloid-beta: a crucial factor in Alzheimer’s disease. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2015;24:1-10.
[51] Alvarez S, Blanco A, Fresno M, Munoz-Fernandez MA. TNF-alpha contributes to caspase-3 independent apoptosis in neuroblastoma cells: role of NFAT. PloS one 2011;6:e16100.
[52] Zhao M, Cribbs DH, Anderson AJ, Cummings BJ, Su JH, Wasserman AJ, et al. The induction of the TNFalpha death domain signaling pathway in Alzheimer’s disease brain. Neurochemical research 2003;28:307-18.
[53] Aybek H, Ercan F, Aslan D, Şahiner T. Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer’s disease in Denizli, Turkey. Clinical Biochemistry 2007;40:172-6.
[54] Rani P, Krishnan S, Rani Cathrine C. Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis. Frontiers in neurology 2017;8:328.
[55] Sunday O, Adekunle M, Temitope O, Richard A, Samuel A, Olufunminyi A, et al. Alteration in antioxidants level and lipid peroxidation of patients with neurodegenerative diseases {Alzheimer’s disease and Parkinson disease}. International Journal of Nutrition, Pharmacology, Neurological Diseases 2014;4:146-52.
[56] Hu LF, Wong PT, Moore PK, Bian JS. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. Journal of neurochemistry 2007;100:1121-8.
[57] Salmina AB, Komleva YK, Szijarto IA, Gorina YV, Lopatina OL, Gertsog GE, et al. H2S- and NO-Signaling Pathways in Alzheimer’s Amyloid Vasculopathy: Synergism or Antagonism? Frontiers in physiology 2015;6:361.
[58] Rose P, Moore PK, Zhu YZ. H2S biosynthesis and catabolism: new insights from molecular studies. Cellular and molecular life sciences : CMLS 2017;74:1391-412.
[59] Eto K, Ogasawara M, Umemura K, Nagai Y, Kimura H. Hydrogen Sulfide Is Produced in Response to Neuronal Excitation. The Journal of Neuroscience 2002;22:3386.
[60] Shibuya Y, Chang CC, Chang TY. ACAT1/SOAT1 as a therapeutic target for Alzheimer’s disease. Future medicinal chemistry 2015;7:2451-67.
[61] Chang TY, Chang CC, Bryleva E, Rogers MA, Murphy SR. Neuronal cholesterol esterification by ACAT1 in Alzheimer’s disease. IUBMB life 2010;62:261-7.
[62] Huttunen HJ, Kovacs DM. ACAT as a drug target for Alzheimer’s disease. Neuro-degenerative diseases 2008;5:212-4.
[63] George AK, Behera J, Kelly KE, Zhai Y, Tyagi N. Hydrogen sulfide, endoplasmic reticulum stress and alcohol mediated neurotoxicity. Brain research bulletin 2017;130:251-6.
[64] Gao C, Chang P, Yang L, Wang Y, Zhu S, Shan H, et al. Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells. International journal of molecular medicine 2018;41(1):242-50.
[65] Zhang JY, Ding YP, Wang Z, Kong Y, Gao R, Chen G. Hydrogen sulfide therapy in brain diseases: from bench to bedside. Medical gas research 2017;7:113-9.
[66] Li G, Yang Y, Dong HJ, Lin L. The research progress of mesenchymal stem cells in the treatment of Traumatic brain injury. Turkish neurosurgery 2017;10:5137-5149
[67] Zhang M, Shan H, Chang P, Wang T, Dong W, Chen X, et al. Hydrogen sulfide offers neuroprotection on traumatic brain injury in parallel with reduced apoptosis and autophagy in mice. PloS one 2014;9:e87241.
[68] Nagpure BV, Bian J-S. Hydrogen Sulfide Inhibits A2A Adenosine Receptor Agonist Induced β-Amyloid Production in SH-SY5Y Neuroblastoma Cells via a cAMP Dependent Pathway. PloS one 2014;9:e88508.
[69] Nogueira JE, Soriano RN, Fernandez RA, Francescato HD, Saia RS, Coimbra TM, et al. Effect of Physical Exercise on the Febrigenic Signaling is Modulated by Preoptic Hydrogen Sulfide Production. PloS one 2017;12:e0170468.
[70] Rosario-Alomar MF, Quinones-Ruiz T, Kurouski D, Sereda V, Ferreira EB, Jesus-Kim LD, et al. Hydrogen sulfide inhibits amyloid formation. The journal of physical chemistry B 2015;119:1265-74.
[71] Zhang Q, Lu Y, Bian H, Guo L, Zhu H. Activation of the α7 nicotinic receptor promotes lipopolysaccharide-induced conversion of M1 microglia to M2. American Journal of Translational Research 2017;9:971-85.
[72] Cheung SH, Kwok WK, To KF, Lau JY. Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene. PloS one 2014;9:e113038.
[73] Mani S, Li H, Untereiner A, Wu L, Yang G, Austin RC, et al. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation 2013;127:2523-34.
[74] Zhao Y, Wei H, Kong G, Shim W, Zhang G. Hydrogen sulfide augments the proliferation and survival of human induced pluripotent stem cell-derived mesenchymal stromal cells through inhibition of BKCa. Cytotherapy 2013;15:1395-405.
[75] Babaei P, Soltani Tehrani B, Alizadeh A. Transplanted Bone Marrow Mesenchymal Stem Cells Improve Memory in Rat Models of Alzheimer’s Disease. Stem Cells International 2012;2012:8.
[76] Amemori T, Jendelova P, Ruzicka J, Urdzikova LM, Sykova E. Alzheimer’s Disease: Mechanism and Approach to Cell Therapy. International journal of molecular sciences 2015;16:26417-51.
[77] Gu W, Song L, Li XM, Wang D, Guo XJ, Xu WG. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Scientific reports 2015;5:8733.
[78] Naaldijk Y, Jager C, Fabian C, Leovsky C, Bluher A, Rudolph L, et al. Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice. Neuropathology and applied neurobiology 2017;43:299-314.
[79] Neirinckx V, Coste C, Rogister B, Wislet-Gendebien S. Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem cells translational medicine 2013;2:284-96.
[80] Turgeman G. The therapeutic potential of mesenchymal stem cells in Alzheimer’s disease: converging mechanisms. Neural Regen Res 2015;10:698-9.
[81] Yun HM, Kim HS, Park KR, Shin JM, Kang AR, il Lee K, et al. Placenta-derived mesenchymal stem cells improve memory dysfunction in an Abeta1-42-infused mouse model of Alzheimer’s disease. Cell death & disease 2013;4:e958.
[82] Li C, Guo Z, Guo B, Xie Y, Yang J, Wang A. Inhibition of the endogenous CSE/H(2)S system contributes to hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Molecular medicine reports 2014;9:2467-72.
[83 Yang R, Liu Y, Shi S. Hydrogen Sulfide Regulates Homeostasis of Mesenchymal Stem Cells and Regulatory T Cells. Journal of dental research 2016;95:1445-51.
[84] Calio ML, Marinho DS, Ko GM, Ribeiro RR, Carbonel AF, Oyama LM, et al. Transplantation of bone marrow mesenchymal stem cells decreases oxidative stress, apoptosis, and hippocampal damage in brain of a spontaneous stroke model. Free radical biology & medicine 2014;70:141-54.
[85] Abdel Aziza MT, Atta HM, Samer H, Ahmed HH, Rashed LA, Sabry D, et al. Heme oxygenase effect on mesenchymal stem cells action on experimental Alzheimer’s disease. EXCLI journal 2013;12:778-92.
[86] Frodermann V, van Duijn J, van Pel M, van Santbrink PJ, Bot I, Kuiper J, et al. Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development. Scientific reports 2015;5:15559.
[87] Giuliani D, Ottani A, Zaffe D, Galantucci M, Strinati F, Lodi R, et al. Hydrogen sulfide slows down progression of experimental Alzheimer’s disease by targeting multiple pathophysiological mechanisms. Neurobiol Learn Mem 2013;104:82-91.
[88] Luo Y, Smith JV, Paramasivam V, Burdick A, Curry KJ, Buford JP, et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A 2002;99:12197-202.
[89] Rhein V, Giese M, Baysang G, Meier F, Rao S, Schulz KL, et al. Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure. PloS one 2010;5:e12359.
[90] Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, Klein WL, et al. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26:13102-13.